Patients with chronic kidney disease (CKD) and heart failure may not be getting the same benefits associated with use of an implantable cardioverter-defibrillator (ICD) as patients with heart failure ...

Rochester, NY - MI patients with disease severity ranging from New York Heart Association (NYHA) class 1 to 3 benefited from an implantable cardioverter-defibrillator (ICD), according to a secondary ...

February 8, 2005 — The investigational agent, azimilide dihydrochloride, a class III antiarrhythmic drug with potassium channel-blocking properties, significantly reduces the need for shocks or ...

After 5 years, approximately one in four patients treated with an implantable cardioverter-defibrillator (ICD) will require reoperation, a new study shows. And while the reoperation rate varies ...

Implantable cardioverter defibrillators (ICDs) were found to have a beneficial effect on mortality in patients with chronic kidney disease (CKD). Mortality in patients with chronic kidney disease (CKD ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In certain patients with an ICD for primary prevention, ...

Implantable cardioverter-defibrillator (ICD) use is associated with reduced short- and long-term mortality in patients with heart failure, according to late breaking research presented in a Hot Line ...

Patients receiving an implantable cardioverter defibrillator (ICD) should be regularly screened for anxiety and depression, according to research presented at EHRA 2021, an online scientific congress ...

Please provide your email address to receive an email when new articles are posted on . Remote ICD deactivation for patients receiving hospice care was successful in a small feasibility study.

"Appropriately selected patients with NICM have the potential to benefit from primary prevention ICD therapy…Besides consideration of ICD placement, attention to guideline-directed medical therapy and ...

heart ecg For patients with symptomatic systolic heart failure not caused by coronary artery disease, an implantable cardioverter-defibrillator (ICD) does not reduce the risk of all-cause mortality, ...

The presence of a cardiovascular implantable electronic device has long been a contraindication for the performance of magnetic resonance imaging (MRI). We established a prospective registry to ...